Focus: Libra Therapeutics is a newly founded (2024) San Diego-based biotechnology company focused on small-molecule therapeutics for neurodegenerative indications. The company is in very early stage with minimal public disclosure on scale or financials.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
High-risk, high-reward early-stage play suitable only for founders-track candidates comfortable with significant uncertainty and portfolio diversification.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Libra Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Libra Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo